🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

November Issue: #CirculatingTumorDNA in the Monitoring of Soft Tissue #Sarcoma Treatment and Recurrence Beatrice Sun rdcu.be/d0L4V Thuy Tran, MD Syed A. Ahmad

We are pleased to announce that Annals of Thoracic Surgery Short Reports has been accepted for indexing in PubMed Central! Read more👇 sts.org/press-releases…

The ins and outs of this landmark ESOPEC trial will be presented at OGOS2025 by the senior author Peter Grimminger! Not to be missed! Register asap to avoid missing out cvent.me/Z5oXQL?RefId=O…

📸 Congratulations to the 2024-25 #STSLeadershipInstitute cohort! 🎉 Your hard work, dedication, and commitment to leadership excellence inspire us all. 🌟 We can’t wait to see how you’ll shape the future of cardiothoracic surgery. 💼✨ #STS2025

Best session ever. Vulnerability Makes Us Whole at the The Society of Thoracic Surgeons Annual Mtg. Frank & personal discussion of surgeon mental health, headlined by one of my personal heroes, Dr. Carrie Cunningham, who gave the most courageous pres. address ever. youtu.be/JaNBH4UPHv4?si…

The Society of Thoracic Surgeons #STS2025 late breaking abstract of GTS database + long-term outcomes makes us think twice about doing a wedge resection for #lungcancer; and the comparison of #segmentectomy over #wedge resection

Early detection saves lives. This #BlackHistoryMonth, we’re highlighting the importance of #lungcancer screening in Black communities. Black men face a higher risk of aggressive lung cancer, but screenings can make a difference. Learn more: bit.ly/3EyLj3U

Very excited to share our most recent manuscript 🫁! Outcomes After Surgical Management of Early-Stage Lung Cancer in Octogenarians: An in-depth Analysis of a Nationally Representative Cohort - Journal of Thoracic Oncology jto.org/article/S1556-…

Most viewed in the last 7 days from JAMA Surgery: Neoadjuvant chemoimmunotherapy improves 2-year overall survival and disease-free survival compared with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. ja.ma/3FXLHcP

Most viewed in the last 7 days from JAMA Surgery: Neoadjuvant chemoimmunotherapy improves 2-year overall survival and disease-free survival compared with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. ja.ma/440ciQu

Join us for the next Inside the Operating Room webinar with Dr. Ian Bostock, a leader in thoracic surgery and surgical innovation! 🗓️Date: April 22, 2025 ⏰Time: 5pm PST / 8pm EST Register: partners.zoom.us/meeting/regist…

Clear, grounded, genuinely helpful! A must-watch from Mara Antonoff, MD, FACS: lays out why surgery can be right for some with oligometastatic #lungcancer. Big implications for how we talk about stage IV. Via Lung Cancers Today 🙏. #LCSM

Love having this tremendous intellectual power focused on creating a world where no one dies from lung cancer. #ThisIsHope #ASCO25 #lcsm

Early-career surgeons face high vulnerability to moral injury from complications and poor outcomes. Building “protective equity” through mentorship and peer support may mitigate long-term harm. journals.lww.com/annalsofsurger…

Thank you Sara! This was a very fun experience that I hope helps inspire incoming applicants 🔥

Totally agree! We have to be more proactive! 🥊

Smoking may be in your past, but its effects can linger long after you’ve quit. #Lungcancer doesn’t always come with symptoms early on. Dr. Bostock shares why early detection through screening is so important especially for those with a history of smoking.

AIM-HIGH trial published in Lancet Molecular high-risk stage IA-IIA NSCLC as determined by 14-gene assay with improved survival with adjuvant chemo. It is not often we see survival curves like this in early stage lung cancer. thelancet.com/journals/lanre…